Can-Fite BioPharma annual total assets
2017
2018
2019
2020
2021
2022
2023
2024
2025
Can-Fite BioPharma Total Assets Growth & History (CANF)
Can-Fite BioPharma's total assets was $9.5M for fiscal 2025.
View full Can-Fite BioPharma company overviewCan-Fite BioPharma annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9.5M | $394,000 | +4.32% |
| 2024 | 2024-12-31 | $9.1M | −$869,000 | −8.70% |
| 2023 | 2023-12-31 | $10.0M | $706,000 | +7.61% |
| 2022 | 2022-12-31 | $9.3M | −$11.0M | −54.16% |
| 2021 | 2021-12-31 | $20.3M | $10.7M | +112.67% |
| 2020 | 2020-12-31 | $9.5M | $1.3M | +16.50% |
| 2019 | 2019-12-31 | $8.2M | $222,000 | +2.79% |
| 2018 | 2018-12-31 | $8.0M | $338,000 | +4.44% |
| 2017 | 2017-12-31 | $7.6M | — | — |
Can-Fite BioPharma quarterly total assets
Q4.17
Q2.18
Q4.18
Q2.19
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $9.5M | $394,000 | +4.32% |
| Q2 2025 | 2025-06-30 | $7.7M | $1.8M | +30.36% |
| Q4 2024 | 2024-12-31 | $9.1M | −$869,000 | −8.70% |
| Q2 2024 | 2024-06-30 | $5.9M | −$5.1M | −46.32% |
| Q4 2023 | 2023-12-31 | $10.0M | $706,000 | +7.61% |
| Q2 2023 | 2023-06-30 | $11.0M | −$3.7M | −25.19% |
| Q4 2022 | 2022-12-31 | $9.3M | −$11.0M | −54.16% |
| Q2 2022 | 2022-06-30 | $14.7M | $5.1M | +52.33% |
| Q4 2021 | 2021-12-31 | $20.3M | $10.7M | +112.67% |
| Q2 2021 | 2021-06-30 | $9.7M | −$3.1M | −24.38% |
| Q4 2020 | 2020-12-31 | $9.5M | $1.3M | +16.50% |
| Q2 2020 | 2020-06-30 | $12.8M | −$867,000 | −6.34% |
| Q4 2019 | 2019-12-31 | $8.2M | $222,000 | +2.79% |
| Q2 2019 | 2019-06-30 | $13.7M | $2.7M | +24.43% |
| Q4 2018 | 2018-12-31 | $8.0M | $338,000 | +4.44% |
| Q2 2018 | 2018-06-30 | $11.0M | — | — |
| Q4 2017 | 2017-12-31 | $7.6M | — | — |
Can-Fite BioPharma total assets trends
Over the last five fiscal years, Can-Fite BioPharma's total assets decreased from $9.5M to $9.5M, a change of −$9,000. The latest reported quarter, Q4 2025, shows $9.5M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Can-Fite BioPharma source filings ↗